Janssen to Present Data in Treatment-Resistant Depression, Schizophrenia, Health Economics and Outcomes and ... - PR Newswire (press release)

Submitted by Anonymous (not verified) on Thu, 05/03/2018 - 12:05

Janssen to Present Data in Treatment-Resistant Depression, Schizophrenia, Health Economics and Outcomes and ...PR Newswire (press release)TITUSVILLE, N.J., May 3, 2018 /PRNewswire/ -- The first data from two Phase 3 studies of the investigational compound esketamine nasal spray in patients with treatment-resistant depression are among 17 abstracts from the Janssen Pharmaceutical ...